CrushSCI.com
116.1Average days
125Median days
62Fastest days
171Longest days
842025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

107 days

Double heterozygous pathogenic germline APC and MSH2 variants in a 16-year-old female diagnosed with colorectal cancer

Authors
Elena Maccaroni; Riccardo Bacalini; Alessia Lancianese; Cecilia Copparoni; Riccardo Giampieri; Francesca Bianchi; C. Brugiati; Laura Belvederesi; Elisa Ambrosini; Natalia Chiodi; Emma Nicol Serritelli; Giulia Ricci; Valentina Tarantino; Manuela Santarosa; Francesca Morgese; Alice Magnarini; Silvia Villani; Veronica Agostinelli; Giulia Mentrasti; Alessandra Mandolesi; Gaia Goteri; Paola Coccia; Rossana BerardiShow moreShow less
Affiliations
1. Azienda Ospedaliero-Universitaria delle Marche; 2. Marche Polytechnic University; 3. Oncology Unit, "Santa Maria Della Misericordia" Hospital, 61029, Urbino, Italy; 4. Centro di Riferimento OncologicoShow moreShow less
Source PDF DOI Publisher page
125 days

Optimizing MRI sequences and apparent diffusion coefficient parameters for small pancreatic ductal adenocarcinoma detection

Authors
Naoko MoriShow moreShow less
Affiliations
1. Department of Radiology, Akita University Graduate School of Medicine, Akita, JapanShow moreShow less
Source PDF DOI Publisher page
156 days

Addressing uncertainty in hereditary colorectal cancer: the role of a regional expert multidisciplinary team meeting

Authors
Avani Varde; Terri McVeigh; Vicky Cuthill; Angela F. Brady; Bianca DeSouza; Andrew Latchford; Kevin J. MonahanShow moreShow less
Affiliations
1. The Centre for Familial Intestinal Cancer, St Mark’s The National Bowel Hospital, London, UK; 2. Surgery and Cancer, Imperial College, London, UK; 3. The Royal Marsden Hospital, London, UK; 4. North West Thames Regional Genetics Service, London, UKShow moreShow less
Source PDF DOI Publisher page
157 days

Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study

Authors
Serene Ong; Zi Yang Chua; Jeanette Yuen; Jianbang Chiang; Zhang Zewen; Joanne Ngeow; Tamra LysaghtShow moreShow less
Affiliations
1. Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 2. Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore; 3. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; 4. Sydney Health Ethics, University of Sydney, Sydney, AustraliaShow moreShow less
Source PDF DOI Publisher page
171 days

A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer

Authors
Fernández Mercè; Queralt Asla; Francisco J. Illana; Fusté Victòria; Hernández-Losa Javier; Sesé Marta; Carmela Iglesias; Susan M. Webb; Anna AulinasShow moreShow less
Affiliations
1. Department of Endocrinology and Nutrition, Institut de Recerca Sant Pau (IR SANTPAU), Endo-ERN. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 2. Department of Endocrinology and Nutrition, Centre d’Atenció Integral Dos de Maig, Consorci Sanitari Integral, Barcelona, Spain; 3. Faculty of Medicine, University of Vic-Central University of Catalonia, Vic, Spain; 4. Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain; 5. Department of Pathological Anatomy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 6. Department of Pathological Anatomy, Vall d’Hebrón Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain; 7. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; 8. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Instituto de Salud Carlos III (ISCIII), Madrid, SpainShow moreShow less
Source PDF DOI Publisher page
143 days

CHEK2 -related breast cancer: real-world challenges

Authors
Luiza N. Weis; Brittany L. Bychkovsky; Adela Rodríguez Hernandez; Romualdo Barroso-Sousa; Renata L. SandovalShow moreShow less
Affiliations
1. Dasa Oncology, Hospital Brasília, Brasília, Brazil; 2. Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, USA; 3. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 4. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; 5. Harvard Medical School, Boston, USA; 6. Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; 7. Department of Medicine, University of Barcelona, Barcelona, Spain; 8. Hospital Sírio-Libanês, Brasília, BrazilShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Familial Cancer take to review a manuscript?

As of 2026-11-19, CrushSCI has 11 complete review records for Familial Cancer. The fastest paper went from submission to acceptance in 62 days (New RPS20 gene variant in colorectal cancer diagnosis: insight from a large series of patients, received 2024-11-28, accepted 2025-01-29); the slowest took 171 days. The average is 116.1 days and the median is 125 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.